Visualization of the Cardiac Venous System Using Cardiac Magnetic Resonance

American Journal of Cardiology

Volumn 101, Issue 3, 2008, Pages 407-412

  Chiribiri, Amedeo ^a   Kelle, Sebastian ^b   Götze, Stephan ^b   Kriatselis, Charalampos ^b   Thouet, Thomas ^b   Tangcharoen, Tarinee ^b   Paetsch, Ingo ^b   Schnackenburg, Bernhard ^c   Fleck, Eckart ^b   Nagel, Eike ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOFOSVESET; GADOMER 17;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY SINUS; FEMALE; HUMAN; IMAGING SYSTEM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

CONTRAST MEDIA; CORONARY VESSELS; FEASIBILITY STUDIES; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES;

EID: 38849183446     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.08.049     Document Type: Article

References (30)

1. Ortale J.R., Gabriel E.A., Iost C., and Marquez C.Q. The anatomy of the coronary sinus and its tributaries. Surg Radiol Anat 23 (2001) 15-21
2. von Ludinghausen M. The venous drainage of the human myocardium. Adv Anat Embryol Cell Biol 168 (2003) 1-104
3. Jongbloed M.R., Lamb H.J., Bax J.J., Schuijf J.D., de Roos A., van der Wall E.E., and Schalij M.J. Noninvasive visualization of the cardiac venous system using multislice computed tomography. J Am Coll Cardiol 45 (2005) 749-753
4. Gerber T.C., Sheedy P.F., Bell M.R., Hayes D.L., Rumberger J.A., Behrenbeck T., Holmes Jr. D.R., and Schwartz R.S. Evaluation of the coronary venous system using electron beam computed tomography. Int J Cardiovasc Imaging 17 (2001) 65-75
5. Mao S., Shinbane J.S., Girsky M.J., Child J., Carson S., Oudiz R.J., and Budoff M.J. Coronary venous imaging with electron beam computed tomographic angiography: three-dimensional mapping and relationship with coronary arteries. Am Heart J 150 (2005) 315-322
6. Van de Veire N.R., Schuijf J.D., De Sutter J., Devos D., Bleeker G.B., de Roos A., van der Wall E.E., Schalij M.J., and Bax J.J. Non-invasive visualization of the cardiac venous system in coronary artery disease patients using 64-slice computed tomography. J Am Coll Cardiol 48 (2006) 1832-1838
7. Diamond G.A., and Forrester J.S. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 300 (1979) 1350-1358
8. Herborn C.U., Barkhausen J., Paetsch I., Hunold P., Mahler M., Shamsi K., and Nagel E. Coronary arteries: contrast-enhanced MR imaging with SH L 643A-experience in 12 volunteers. Radiology 229 (2003) 217-223
9. Parmelee D.J., Walovitch R.C., Ouellet H.S., and Lauffer R.B. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 32 (1997) 741-747
10. Lauffer R.B., Parmelee D.J., Dunham S.U., Ouellet H.S., Dolan R.P., Witte S., McMurry T.J., and Walovitch R.C. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 207 (1998) 529-538
11. Bluemke D.A., Stillman A.E., Bis K.G., Grist T.M., Baum R.A., D'Agostino R., Malden E.S., Pierro J.A., and Yucel E.K. Carotid MR angiography: phase II study of safety and efficacy for MS-325. Radiology 219 (2001) 114-122
12. Grist T.M., Korosec F.R., Peters D.C., Witte S., Walovitch R.C., Dolan R.P., Bridson W.E., Yucel E.K., and Mistretta C.A. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 207 (1998) 539-544
13. Nassenstein K., Waltering K.U., Kell S., Schlosser T., Breuckmann F., Maderwald S., Hunold P., Nagel E., and Barkhausen J. Magnetic resonance coronary angiography with Vasovist trademark: in-vivo T (1) estimation to improve image quality of navigator and breath-hold techniques. Eur Radiol (2007) in press
14. Weber O.M., Martin A.J., and Higgins C.B. Whole-heart steady-state free precession coronary artery magnetic resonance angiography. Magn Reson Med 50 (2003) 1223-1228
15. Jahnke C., Paetsch I., Nehrke K., Schnackenburg B., Gebker R., Fleck E., and Nagel E. Rapid and complete coronary arterial tree visualization with magnetic resonance imaging: feasibility and diagnostic performance. Eur Heart J 26 (2005) 2313-2319
16. Prakken N.H., Vonken E.J., Velthuis B.K., Doevendans P.A., and Cramer M.J. 3D MR coronary angiography: optimization of the technique and preliminary results. Int J Cardiovasc Imaging 22 (2006) 477-487
17. Gilard M., Mansourati J., Etienne Y., Larlet J.M., Truong B., Boschat J., and Blanc J.J. Angiographic anatomy of the coronary sinus and its tributaries. Pacing Clin Electrophysiol 21 (1998) 2280-2284
18. Meisel E., Pfeiffer D., Engelmann L., Tebbenjohanns J., Schubert B., Hahn S., Fleck E., and Butter C. Investigation of coronary venous anatomy by retrograde venography in patients with malignant ventricular tachycardia. Circulation 104 (2001) 442-447
19. Paetsch I., Jahnke C., Barkhausen J., Spuentrup E., Cavagna F., Schnackenburg B., Huber M., Stuber M., Fleck E., and Nagel E. Detection of coronary stenoses with contrast enhanced, three-dimensional free breathing coronary MR angiography using the gadolinium-based intravascular contrast agent gadocoletic acid (B-22956). J Cardiovasc Magn Reson 8 (2006) 509-516
20. Abraham W.T., and Hayes D.L. Cardiac resynchronization therapy for heart failure. Circulation 108 (2003) 2596-2603
21. Puglisi A., Lunati M., Marullo A.G., Bianchi S., Feccia M., Sgreccia F., Vicini I., Valsecchi S., Musumeci F., and Vitali E. Limited thoracotomy as a second choice alternative to transvenous implant for cardiac resynchronisation therapy delivery. Eur Heart J 25 (2004) 1063-1069
22. Razavi R., Hill D.L., Keevil S.F., Miquel M.E., Muthurangu V., Hegde S., Rhode K., Barnett M., van Vaals J., Hawkes D.J., and Baker E. Cardiac catheterisation guided by MRI in children and adults with congenital heart disease. Lancet 362 (2003) 1877-1882
23. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 21 (2006) 1104-1108
24. Dharnidharka V.R., Wesson S.K., and Fennell R.S. Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 22 (2007) 1395
25. Boyd A.S., Zic J.A., and Abraham J.L. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 56 (2007) 27-30
26. Pennell D.J., Sechtem U.P., Higgins C.B., Manning W.J., Pohost G.M., Rademakers F.E., van Rossum A.C., Shaw L.J., and Yucel E.K. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. J Cardiovasc Magn Reson 6 (2004) 727-765
27. Hendel R.C., Patel M.R., Kramer C.M., Poon M., Carr J.C., Gerstad N.A., Gillam L.D., Hodgson J.M., Kim R.J., and Lesser J.R. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 48 (2006) 1475-1497
28. Martin E.T., Coman J.A., Shellock F.G., Pulling C.C., Fair R., and Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 43 (2004) 1315-1324
29. Nazarian S., Roguin A., Zviman M.M., Lardo A.C., Dickfeld T.L., Calkins H., Weiss R.G., Berger R.D., Bluemke D.A., and Halperin H.R. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 114 (2006) 1277-1284
30. Faris O.P., and Shein M. Food and Drug Administration perspective: magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation 114 (2006) 1232-1233